Pharmacological effects of an aldehyde type α/β-adrenoceptor blocking agent with vasodilating properties

General Pharmacology: The Vascular System

Volumn 34, Issue 6, 2000, Pages 391-400

  Chiu, Chaw Chi ^a   Lin, Young Tso ^a   Tsai, Chieh Ho ^b   Liang, Jhy Chong ^b   Chiang, Lien Chai ^a   Wu, Jiunn Ren ^a   Chen, Ing Jun ^b   Yeh, Jwu Lai ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adrenoceptor blockade; Intrinsic sympathomimetic activity; Radioligand binding assay; Vasorelaxant effect

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ISOPRENALINE; KMUP 880723; LABETALOL; MECAMYLAMINE; NORADRENALIN; PHENYLEPHRINE; POTASSIUM ION; PRAZOSIN; PROPRANOLOL; RESERPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CHRONOTROPISM; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; FEMALE; GUINEA PIG; HEART ATRIUM; HYPOTENSION; INOTROPISM; LIGAND BINDING; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; TACHYCARDIA; THORACIC AORTA; TRACHEA; VASODILATATION;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AORTA; ATENOLOL; BENZALDEHYDES; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HEART ATRIA; HEART RATE; ISOPROTERENOL; LABETALOL; MECAMYLAMINE; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; PROPRANOLOL; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; REGRESSION ANALYSIS; STIMULATION, CHEMICAL; VASODILATOR AGENTS;

EID: 0034434577     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(01)00076-3     Document Type: Article

References (30)

1. The beta 1- and 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: A study in the isolated right atrium and uterus of the rat
2. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
3. The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues
4. Xanthonolol: A calcium channel and β-adrenoceptor blocker with vasodilating properties
5. Guaiacoxypropanolamine derivatives of capsaicin: A new family of β-adrenoceptor blockers with intrinsic cardiotonic properties
6. Capsinolol: The first β-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart
7. 2-agonist and calcium mobilization inhibition associated vasorelaxant activities
8. Beta-blockers in heart failure: Promising or proved?
9. The beta 1-adrenoceptor antagonist, betaxolol, is not released from the heart of the anaesthetized dog during sympathetic nerve stimulation
10. Clinical perspective on celiprolol: Cardioprotective potential
11. Calcium antagonizm and calcium entry blockade
12. 2+ in smooth muscle
13. 2-adrenoceptor agonist-associated vasorelaxant activities
14. 2-agonist activity
15. Effect of low dose β blockers on arterial and ventricular (B type) natriuretic factor in heart failure: A double blind, randomized comparison of metoprolol and a third generation vasodilating β blocker
16. Labedipinedilol-A: A vanilloid-based α/β-adrenoceptor blocker with calcium entry blocking and long acting anti-hypertensive properties
17. 1-adrenoceptor antagonist
18. 1-adrenoceptor antagonist with tracheal and vascular smooth muscle relaxant properties
19. Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents
20. ICI 118,551: An effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects
21. Carbonyl-trapping therapeutic strategies
22. Vanidilol: A vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity
23. Pharmacological profile of carvedilol as a β-blocking agent with vasodilating and hypotensive properties
24. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain
25. 1-adrenoceptor blocking agent
26. Zingeronolol: A newly developed β-adrenoceptor blocking agent derived from zingerone, a pungent principle of ginger
27. 2-agonist activity derived from ferulic acid, an active component of Ligusticum wallichii Franch
28. Cardiovascular interactions of nonivamide, glyceryl nonivamide, capsaicin analgues, and substance P antagonist in rats
29. Vanidipinedilol: A vanilloid-based β-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities
30. Isoeugenodilol: A vasorelaxant α/β-adrenoceptor blocker with antioxidant activities